English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
Integrating an Iboga Experience: What Actually Happens After the Ceremony
Most people walk into an iboga ceremony bracing for the experience itself — the long hours, the visions, the physical weight of the medicine pressing them into the mat. What almost no one prepares for is what comes after. The ceremony ends. You go home. And then? Then the actual work starts. Iboga, the root bark from a small West African shrub used for centuries in Bwiti tradition, is one of the most demanding plant medicines on the planet. It's also one of the most studied for addiction recovery — particularly opioid dependency. But here's the thing nobody at the retreat will quite tell you straight: the medicine doesn't fix you. It shows you. What you do with what it shows you is the entire ballgame. There's a tempting story floating around the psychedelic healing space — that one heroic dose will rewire your brain, dissolve your addiction, and hand you back a new life. People do report dramatic shifts after iboga, especially around opioid cravings. That part is real. What gets glossed over is the window. After a flood dose of ibogaine or traditional iboga root bark, many people describe a period — sometimes called the gray day, sometimes stretching into weeks — where old cravings are quiet, old patterns feel optional, and the mind is unusually pliable. This isn't a permanent state. It's an opening. Treat it like a runway, not a destination. Without integration, that window closes and the old grooves reassert themselves. With integration, you can build new grooves while the soil is soft. The difference between people who hold their gains and people who relapse within six months is almost always what they did between week one and month six. Right after an iboga experience, you may feel clear in a way you haven't felt in years. Clean. Lucid. Convinced that everything has changed. That feeling is partly real and partly a chemical afterglow, and it's a terrible time to make big decisions. People in this phase quit jobs, end relationships, move countries, announce sweeping life pivots — and a fair number regret it three months later when the high tide of insight has receded and they're left looking at the wreckage. The medicine showed you something true, probably. But truth and timing are different animals. Move slowly. Eat real food. Walk outside. Write things down before you forget them, because you will forget them. Integration isn't a mystical process. It's mostly mundane, daily, and a bit boring — which is exactly why people skip it. Here's what tends to work, drawn from what facilitators and people who've sustained their changes actually do. For the first week, sit down every morning and write whatever you remember. Visions, conversations with whatever you encountered, body sensations, names of people who appeared, regrets that surfaced. Don't edit. Iboga insights have a strange half-life — vivid for ten days, then they start dissolving. The journal is your archive. Talking to people who haven't done plant medicine about a plant medicine experience is mostly frustrating. They'll either be politely baffled or quietly worried about you. Find one person — a facilitator who offers integration calls, a therapist trained in psychedelic integration, a peer from your retreat — who can hear what you're saying without translating it into something smaller. One real conversation beats ten polite ones. Iboga tends to show people a long list of things that aren't working. Trying to fix all of them at once is how people burn out and end up back where they started. Choose one. Maybe it's the relationship you keep avoiding. Maybe it's the substance you keep returning to. Maybe it's the work schedule that's been quietly killing you. One thing, attacked seriously, will do more for you than ten things attacked half-heartedly. Iboga is a deeply somatic medicine — it lives in the body for a long time, and the insights it surfaces are often stored in the body too. Some kind of regular physical practice helps the integration land: walking, swimming, yoga, breathwork, simple stretching. Nothing extreme. The goal is to stay in contact with yourself, not to optimize a fitness routine. Ibogaine has a serious track record in interrupting opioid dependency. Clinics in Mexico, Costa Rica, and a handful of other jurisdictions have been treating heroin and prescription opioid addiction with it for decades, and the published outcomes are interesting enough that mainstream addiction medicine is finally paying attention. But interrupting is not the same as curing. What ibogaine seems to do reliably is take away the acute withdrawal and reset cravings for a window of time. What it cannot do is rebuild the life you'll re-enter once that window opens. If you go back to the same apartment, the same friends, the same patterns, the same unaddressed trauma — the addiction will find its way home. The people who stay clean after iboga are almost always the ones who treated the medicine as the start of a long process, not the end of a short one. This is why reputable iboga providers increasingly insist on aftercare programs, sober living arrangements, and structured follow-up. If you're considering iboga for addiction and the retreat you're looking at doesn't ask hard questions about your plan for the weeks after — that's a red flag worth paying attention to. A few patterns show up over and over with people who lose ground after an iboga journey: Iboga can surface old material — trauma, grief, suppressed memories — that doesn't always tuck itself back in neatly. Most people handle the unpacking with journaling, peer support, and time. Some people need more, and there's no shame in that. If you're experiencing prolonged sleep disruption past a few weeks, intrusive memories that won't settle, depressive episodes deeper than your baseline, or thoughts of self-harm, that's the moment to find a therapist — ideally one familiar with psychedelic integration, though a competent trauma therapist of any stripe is better than going it alone. Iboga can crack things open that need a professional hand to help close. Plant medicine doesn't replace mental health care. At its best, it accelerates and deepens the work. At its worst, it surfaces things you weren't ready to face. Knowing the difference, and being willing to ask for help, is part of being a serious participant in your own healing. People who've held their iboga insights five and ten years later describe something interesting: the experience itself becomes less central over time, but the small daily decisions they made in the months after — the boundary they finally drew, the job they finally left, the practice they finally committed to — those compound. The ceremony was a doorway. The life on the other side was built one ordinary week at a time. That's the part the brochures don't sell well, because it isn't dramatic. But it's the part that matters. If you're seriously considering iboga for addiction, depression, or a stuck pattern you can't seem to shake, the question to sit with isn't whether the medicine will work. It's whether you're prepared to do the slow, unglamorous work that makes the medicine stick. For readers who want to take this further, a range of carefully vetted iboga and ibogaine retreats can be browsed on our marketplace here. The plant will do its part. The rest is yours.
Why Silicon Valley Founders Are Flying to Peru for Ayahuasca Ceremonies
Somewhere in the Sacred Valley of Peru, between Cusco and Machu Picchu, an adobe temple sits on a ridge overlooking the Andean highlands. Inside, a group of founders — people who normally spend Tuesday mornings arguing about runway and burn rate — are lying on thin mats, waiting for a brew of bitter brown liquid to start dismantling everything they think they know about themselves. This is what an ayahuasca retreat for tech entrepreneurs actually looks like. And it costs roughly the price of a decent used car. The trend isn't new anymore — it's been simmering for over a decade — but the questions around it have only sharpened. Why are so many high-functioning, ambitious people turning to plant medicine? What does it actually do? And is it a legitimate tool for working through stuck patterns, including addiction and burnout, or just the latest expensive thing successful people do to feel something? I've sat in enough ceremonies and interviewed enough facilitators to have opinions on all of that. Let's get into it. The pattern goes back further than most people realize. Steve Jobs talked about LSD as one of the most important experiences of his life. Bill Gates dabbled. Tim Ferriss has been openly discussing psychedelics for years, once comparing ayahuasca in tech circles to grabbing coffee. That's an overstatement — you're not going to find anyone microdosing DMT between standups — but the cultural underground is real. What changed around the mid-2010s was the appearance of structured programs aimed specifically at founders and executives. One of the better-known ones runs small cohorts to Peru each year — usually around 20 people split across two trips, drawn from hardware, software, and fintech startups. The price tag tends to land between $10,000 and $12,000 once you factor in coaching, lodging, ceremony, and the long-haul flights. The founder of one such program once put it bluntly to a reporter: you can spend six years in therapy, or you can spend ten days in the Andes. Red pill or sugar pill? It's a great soundbite. It's also, in my honest opinion, only half true. More on that later. The brew itself is made from the Banisteriopsis caapi vine, often combined with chacruna leaves that contain DMT. Indigenous peoples across the Amazon have been working with this combination for centuries — some traditions say thousands of years — as part of healing and spiritual practice. It's legal in Peru and in a handful of other South American countries. In the United States it sits in a strange grey zone: DMT is Schedule I, but two religious organizations have won the right to use the brew sacramentally. A typical 10-day retreat tends to follow a rhythm something like this: Inside the ceremony itself, the experience varies wildly. Some people describe lucid-dream-like visions — wandering through landscapes, encountering animals, replaying childhood scenes. One past participant of a tech-focused retreat described witnessing himself as a boy in a humiliating moment from grade school and finally, at age forty-something, deciding to put the shame down. Another described leaving her body entirely and watching herself from across the room. A friend of mine swears he spent two hours moving through what he insists was the inside of his own digestive tract, like a deranged children's TV episode. And then there's the vomiting. Almost everyone purges. Practitioners call it cleansing; your body calls it Tuesday. A well-run ayahuasca ceremony has buckets, towels, and absolutely no judgment about any of it. This is the question that brings most thoughtful people to plant medicine in the first place — and it deserves a careful answer. There's a growing body of clinical and observational research suggesting that ayahuasca, psilocybin, and ibogaine can produce meaningful, sometimes durable shifts in people struggling with depression, PTSD, alcohol use disorder, and opioid dependence. Ibogaine in particular has a long track record with opioid addiction — it appears to reset some of the neurochemistry involved in withdrawal and craving. Ayahuasca's effects on addiction seem to work through a different door: not by interrupting the chemistry directly, but by surfacing the emotional material that drives the behavior in the first place. That said — and this matters — psychedelics are not magic. They don't do the work for you. What they do is create an unusual window in which patterns become visible, often painfully so. What you do with that visibility afterward is the actual healing. Facilitators have a word for this: integration. It's the part where you come home, talk through what surfaced with a therapist or coach or trusted friend, and start translating insight into different daily behavior. Skipping integration is the most common mistake I see. People take the trip, have a profound night, fly home, and then six months later wonder why nothing actually changed. The ceremony was the easy part. Let's talk honestly about money, safety, and quality — because this is where retreat-seekers most often get burned. Costs for a reputable ayahuasca retreat in Peru typically range from about $1,500 for a basic week with a local center to $11,000 or more for a high-touch program with executive coaching wrapped around it. Neither extreme is automatically better. I've sat in ceremonies at modest centers run by lineage shamans that were more rigorous and more healing than fancy operations with infinity pools. Price signals nothing in this world. What you actually want to evaluate: The unflattering nickname for sloppy, poorly run ceremonies is “yogahuasca” — a Bay Area knockoff aesthetic stapled onto a sacred practice. The problem isn't confined to California either. As demand has exploded, some operations in Peru have followed the money rather than the lineage. Caveat emptor applies, hard. Plant medicine isn't for everyone, and I'd argue strongly against the “hack your consciousness” framing that tech culture sometimes wraps around it. This isn't a shortcut. It's a serious encounter with your own mind, and the people who get the most from it tend to share a few traits. They've usually tried other things first — therapy, meditation, hard conversations, time off. They have a baseline of psychological stability and aren't in active crisis. They have someone to talk to when they get home. They approach the experience with respect rather than treating it as a novelty item to collect alongside Burning Man and a Wim Hof workshop. And critically, they're willing to sit with discomfort. Ayahuasca isn't fun. It's revelatory, sometimes beautiful, occasionally terrifying, and almost always physically rough. People who want pleasant trips should look elsewhere. The founders I've spoken to who report the most lasting benefit describe specific behavioral changes afterward — quitting jobs that were wrong for them, restructuring how they interact with employees, finally addressing a drinking habit, ending relationships that had been quietly dying for years. The shift isn't mystical. It's that the ceremony made a long-avoided truth impossible to ignore for one night, and they found the nerve to act on it. If you've read this far and you're still curious, a few practical suggestions before you book anything. Read at least three first-person accounts of difficult ceremonies, not just the glowing ones. Talk to someone who's been. If you're on prescription medication, especially antidepressants, consult with a doctor who actually understands plant medicine — not all of them do. Sit with the question of why you want to do this. “To see what it's like” is a fine answer for a wine tasting; it's a thin reason to invite an Amazonian vine into your nervous system for six hours. Give yourself a clear week on the back end with no major commitments. The landing is real, and trying to jump straight into a board meeting after a retreat is how people lose the insights they came for. Find a therapist or integration coach you trust, ideally before you go. For readers who want to take this further, a range of vetted ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Whatever you decide, decide it carefully — this is one of those choices that tends to matter more in the months after than in the moment you book it.
Silent Meditation Retreats: An Honest Guide to Sitting in Stillness
How much actual silence have you had today? Not background-music silence. Not nobody-is-talking-but-the-phone-is-buzzing silence. Real, uninterrupted quiet — the kind where you can hear yourself blink. For most of us, the honest answer is: almost none. We move through days stitched together by notifications, podcasts, traffic, group chats, and the low hum of our own running internal monologue. After enough years of that, the nervous system forgets what stillness even feels like. Which is probably why you ended up here, reading about silent meditation instead of doom-scrolling. This is a practical guide. What silent meditation actually is, where it came from, what happens in your head during a long sit, and what to expect if you decide to book a silent retreat. I'll be honest about the uncomfortable parts too, because the glossy version doesn't help anyone make a real decision. The phrase sounds redundant. Isn't all meditation silent? You sit, you close your eyes, you breathe. Quiet by definition, right? Not quite. A lot of what gets called meditation today is guided — a teacher's voice, a soundtrack, a body-scan recording on an app. Useful, especially for beginners, but it's a different beast. Silent meditation is the unguided cousin. No voice. No music. No bells (well, sometimes one bell to mark the start and end). Just you, your breath, and whatever your mind decides to throw at you. That last part is the catch. The silence on the outside reveals how loud it is on the inside. People who try a serious silent sit for the first time are often shocked by the sheer volume of mental chatter. The practice isn't really about achieving silence — it's about being still enough to notice everything that isn't. There's a useful middle ground worth knowing about. Semi-guided sessions bookend silence with brief instruction — a teacher sets an intention at the start, lets you sit for thirty or sixty minutes, then closes the session with a few words. This is how a lot of beginners ease in. Fully unguided is the traditional form: you arrive, you sit, time passes, you stand up. No one tells you when to focus on your breath or whether you're doing it right. That's both the freedom and the difficulty of it. Silent meditation isn't a wellness trend. It's roughly two and a half thousand years old, with roots in the Buddhist tradition of Vipassana — a word that translates loosely as seeing things as they really are. After the Buddha's enlightenment, he spent the rest of his life teaching variations of this technique across what's now northern India. The practice nearly disappeared from India over the centuries that followed but was preserved, almost by accident, in Burma (now Myanmar). In the twentieth century, a Burmese-Indian teacher named S.N. Goenka brought a stripped-down, secular version back to India and then to the West. The ten-day silent Vipassana retreats people talk about today — the ones with no talking, no phones, no eye contact, no reading — descend directly from that lineage. You can read more about the tradition on Wikipedia's entry on Vipassanā if you want the longer history. This matters because it tells you something about what you're walking into. Silent meditation wasn't designed as a stress-management tool. It was designed as a path toward understanding the nature of the mind. The fact that it also lowers cortisol and helps people sleep better is, in the original framing, almost a side effect. Here's what the brochures rarely spell out: the first two or three days of a silent retreat are often miserable. Not in a dramatic way. In a quiet, gnawing, oh-god-what-have-I-done way. The schedule is brutal by modern standards. Wake-up bell around 4 a.m. Sitting sessions of an hour or longer, repeated through the day, with breaks for simple vegetarian meals and walking. No talking to other students. No journaling. No music. Your phone is locked away. By day two, your knees hurt, your back hurts, and your mind has started serving up every unresolved memory it can find, like a search algorithm that finally got some bandwidth. And then — usually somewhere between day three and day five — something shifts. The chatter doesn't stop, exactly, but you stop being so identified with it. You notice a thought arise and pass without chasing it. You feel a sensation in your shoulder and don't immediately need to interpret it. The shoulders themselves drop a little. You start to understand, in a felt way rather than a conceptual one, what teachers mean when they talk about awareness. What people typically report after a silent retreat: I'll be direct. Long silent retreats are not the right starting point for everyone. If you're in the middle of an acute mental-health crisis, recently bereaved, or working through unprocessed trauma without any therapeutic support, ten days alone with your mind can do more harm than good. Reputable retreat centers will sometimes screen for this. Less reputable ones won't. This is also worth saying given who tends to read posts like this: silent meditation and plant medicine sit in adjacent neighborhoods of the inner-work world, and people often consider both. They do different things. A psychedelic ceremony tends to crack you open quickly; silent meditation teaches you, slowly, how to live inside the opening. Many of the most grounded plant-medicine practitioners I know also sit regularly. The two practices feed each other, but neither is a substitute for the other. Silent retreats vary enormously. Some are donation-based and run by experienced lineage teachers. Some are five-star resort experiences with optional silence. Both can be valuable; they're just different products. A few things worth asking before you book: Cost varies wildly. Donation-based Vipassana courses in the Goenka tradition are genuinely free at point of entry, supported by past students. Boutique silent retreats in places like Bali, Costa Rica, or the south of France can run several thousand dollars for a week. Neither pricing model is automatically better; the question is what fits your situation and what kind of container you need. You don't need to fly anywhere to find out whether this practice resonates. Try sitting in unguided silence for twenty minutes a day for two weeks. No app, no music, no podcast. Set a timer, find a spot, watch your breath, and notice what your mind does. If after two weeks you're still curious — even if you're also frustrated — that's a good sign. A retreat will deepen what's already begun. If after two weeks you feel only resistance and nothing else, that's also useful information. Maybe the timing isn't right, or maybe a guided practice or a different modality is a better entry point. There's no rule that says silent meditation has to be your path. For readers who feel ready to take this further, a range of meditation and contemplative retreats — including silent sits and integration-focused programs — can be browsed on our marketplace here. Take your time choosing. The right container makes an enormous difference, and the silence will still be there when you're ready for it.
Santa, Shamans, and Fly Agaric: The Psychedelic Roots of Christmas
Picture a man in red and white robes, sliding down through a hole in the roof in the dead of winter, leaving gifts beneath an evergreen tree. Sounds like Santa. It also sounds suspiciously like a Siberian shaman on a heavy dose of Amanita muscaria — the fly agaric mushroom that grows at the base of pines and birches across the northern hemisphere. The overlap between this peculiar fungus and our modern Christmas iconography is one of the stranger threads in the broader story of psychedelics and human culture, and once you start pulling on it, the whole sweater of holiday tradition begins to unravel in interesting ways. This isn't fringe internet conspiracy — at least not entirely. Ethnobotanists have been writing about the connection for decades, and while no one can prove a direct line from a Koryak shaman in the 1600s to the Coca-Cola Santa of the 1930s, the parallels are hard to wave away as coincidence. So pour yourself something warm and let's wander through the evidence. The short version: among the Koryak, Kamchadal, Evenki, and other Indigenous peoples of the Russian Far East and Siberia, the fly agaric was — and in some communities still is — a sacred psychoactive. Shamans used it as a tool for divination, especially around the winter solstice, when daylight bottoms out and the new solar year begins to claw its way back. They reportedly dressed in red and white to mirror the mushroom's distinctive cap. They entered yurts (round felt tents) through the smoke hole at the top, because the snow blocked the regular door. They distributed mushrooms as gifts. They spoke of flying through the night sky toward the North Star to gather wisdom for the coming year. Read that paragraph again and tell me you don't see Santa squinting back at you. The red suit. The chimney entry. The sleigh ride. The annual visit on the longest night. None of this is a smoking gun on its own, but the cumulative weight starts to feel like more than a stretch — especially once you bring the reindeer in. Before going further, it's worth being clear-eyed about what Amanita muscaria actually is. It's a mycorrhizal fungus that grows in symbiosis with the roots of certain trees — birch, pine, spruce — which is why it can't be cultivated commercially and has to be foraged. It contains two main active compounds: ibotenic acid and muscimol. Ibotenic acid is essentially the prodrug; the body slowly converts it into muscimol, which is the compound responsible for the bulk of the experience. Importantly, fly agaric is not a classic psychedelic in the way psilocybin mushrooms or ayahuasca are. It doesn't act on serotonin 5-HT2A receptors. Instead, muscimol is a GABA-A agonist — it works on the same receptor system as alcohol and benzodiazepines, just from a very different angle. The result is something more dreamlike, dissociative, and unpredictable than a typical psilocybin journey. Reported effects include: Effects typically peak around three hours in and can last anywhere from ten to twenty-four hours. The raw mushroom is genuinely toxic and people do get seriously sick from eating it improperly. Traditional preparation — drying, repeated boiling, or the rather notorious reindeer-urine method — converts most of the ibotenic acid to muscimol and reduces the worst side effects. This is not a casual snack. The reindeer connection is where the story gets gleefully strange. Reindeer in Siberia love fly agaric. They seek it out, dig it from beneath the snow, and eat it apparently for its psychoactive effect. They tolerate the toxins in ways humans don't. The herders noticed this. They also noticed something else: the muscimol passes through the reindeer's body largely intact and ends up in the urine. So — and there's no polite way to say this — people drank the urine. Either straight from the snow or collected from the animal directly. It was a brilliant pharmacological hack: the reindeer's metabolism filtered out most of the nasty stuff, leaving a relatively cleaner psychoactive product. Some accounts even describe the urine being passed from person to person, with muscimol staying potent through several recyclings. Once you know this, the image of reindeer prancing through the sky with a slightly delirious-looking man in red takes on a whole new dimension. And Rudolph's glowing red nose? Probably a stretch — but the most famous red thing in the snowy north, the thing that made reindeer matter to these cultures in the first place, was a mushroom with a bright red cap. Make of that what you will. The Christmas tree is one of the most curious customs in the Western calendar. Why drag an evergreen indoors in December? Pre-Christian solstice traditions across northern Europe revered evergreens as symbols of life persisting through winter death, and that's the standard explanation. But there's a more specific reading too. Fly agaric only grows beneath certain trees — pines, birches, spruces — because it needs their roots to survive. In Siberian cosmology, these trees were sometimes seen as cosmic axes connecting earth to sky, and the mushrooms that appeared beneath them were considered gifts from the tree itself. Foragers would gather them from under the branches, much the way children today gather presents from under a decorated fir. The drying process adds another layer. To reduce toxicity, the mushrooms were often hung from tree branches to dry in the cold winter air. Bright red caps dangling from evergreen boughs. Sound like ornaments yet? Other accounts mention drying them in stockings hung above the fireplace, the heat slowly removing moisture without cooking off the active compounds. Stockings by the fire. On the longest night of the year. Waiting for something. As these traditions drifted west and tangled with Norse and Sami practice, new versions emerged. There's a thread in Nordic folklore involving Odin riding the night sky on his eight-legged horse Sleipnir during the midwinter Wild Hunt. In some tellings, blood or saliva dripped from the horse's mouth as it galloped, and where those droplets fell, fly agaric mushrooms grew the following season. Eight reindeer. Eight-legged horse. Probably not unrelated. The Sami of northern Scandinavia, who herd reindeer to this day, had their own shamanic traditions involving fly agaric. Their drums were sometimes painted with the mushroom's image. Their noaidi (shamans) wore red and white. Their cosmology mapped neatly onto solstice timing. As Christianity spread north and absorbed local custom — as it almost always did — these elements didn't disappear; they simply got reassigned. Here's where I have to be honest with you. The fly-agaric-equals-Santa theory is popular, it's fun, and parts of it are well-documented. But it's also been disputed by serious scholars. The historian Ronald Hutton, who knows more about British and northern European folk tradition than almost anyone alive, has pushed back on the strongest versions of the claim. He argues that fly agaric use was less widespread than the popular story suggests, that Siberian shamans didn't dress in red and white as a uniform, and that the modern Santa is mostly a product of nineteenth-century American writers and illustrators — Clement Clarke Moore, Thomas Nast — drawing on Dutch Sinterklaas traditions. That's a fair correction. The Coca-Cola red-suit Santa really did come from a 1930s advertising campaign, even if the colour scheme already existed in earlier illustrations. Saint Nicholas of Myra was a real fourth-century bishop with no obvious mushroom connections. And a lot of the more specific claims — about chimneys, about reindeer urine, about gifts under trees — get sharper and more dramatic each time they're retold online. The reasonable middle ground goes like this: Siberian and northern European peoples did use fly agaric ceremonially. Their solstice practices did involve reindeer, evergreens, red-and-white symbolism, and ecstatic flight. These traditions did drift south and west over centuries, mingling with Christian and folk customs. Whether they directly shaped Santa Claus is unprovable — but to say they had zero influence on the broader symbolic vocabulary of midwinter celebration feels equally unsupportable. Fly agaric is having a quiet moment. As psilocybin and ayahuasca have moved into mainstream conversation, Amanita muscaria has crept along behind them, partly because it occupies a strange legal grey zone in many countries — unlike classic psychedelics, it isn't scheduled in most of the US, the UK, or the EU. You can find it sold openly, sometimes in gummies or tinctures, which is not the same as saying it's a good idea to use it casually. It's a different animal from the serotonergic psychedelics most retreat-seekers are researching. The experience is harder to predict, the dose-response curve is steeper, and the risk of an unpleasant or genuinely toxic episode is real. People who work with it traditionally do so with deep knowledge of preparation methods passed down through generations. Most of us don't have that. If you're curious about plant medicine for healing addiction, depression, or trauma, fly agaric is probably not the first door to open — ayahuasca, psilocybin, and ibogaine all have substantially more clinical research and a much longer track record of facilitated, ceremonial use in modern retreat settings. Still, the mushroom matters culturally. It's a reminder that the human relationship with master plants and psychoactive fungi is ancient, that it's woven into rituals we still perform without realising what we're doing, and that the line between religion, medicine, and altered states has always been blurrier than tidy modern categories suggest. If your interest in psychedelics is partly a search for older, deeper ways of marking time and meaning, a range of ayahuasca, psilocybin, and other plant-medicine retreats can be browsed on our marketplace here. Whether or not Santa is a Siberian shaman in disguise, there's something worth holding onto in the story. Midwinter is when human beings have always reached for the strange — for ritual, for light in the dark, for some hint that the year is going to turn and the sun will come back. That instinct predates Christianity, predates Coca-Cola, predates the mushroom theory itself. It probably predates language. So this December, when you string up red and white ornaments and hang stockings by a fire and put presents under an evergreen tree, you might be participating in a tradition far older and weirder than the carols suggest. Worth a quiet nod to the reindeer, at least.
MDMA-Assisted Therapy for Autism and Social Anxiety: What the Research Suggests
Social anxiety isn't shyness. Anyone who's lived inside it knows the difference — the racing pulse before a dinner party, the rehearsed sentences that never quite leave your mouth, the exhaustion of pretending you're fine. For many autistic adults, that experience runs deeper still. Reading a room, parsing tone, tracking the unspoken rules of small talk — these things cost energy most people never have to spend. And the standard treatments? They don't always help. Which is why a study published in the journal Psychopharmacology caught the attention of researchers, clinicians, and a lot of curious readers. The trial was small. The conditions were tightly controlled. But the results hinted at something the psychedelic-therapy field has been quietly building toward for years — that MDMA, used in a clinical setting with trained therapists, might offer real relief for autistic adults living with severe social anxiety. Researchers at the Biomedical Research Institute at Harbor-UCLA Medical Center ran a trial with twelve autistic adults. Half received two MDMA-assisted therapy sessions; half received placebo paired with the same therapeutic structure. Everyone was assessed using the Liebowitz Social Anxiety Scale, a clinical tool that produces a numeric score — higher means more socially anxious. The MDMA group saw an average drop of 44.1 points on the scale. The placebo group dropped 19.3. That's a meaningful gap, especially in a population for whom conventional anti-anxiety medications and talk therapy often fall short. Participants didn't just score lower on a questionnaire — they described feeling, sometimes for the first time, that interacting with other people wasn't a battle to be survived. One participant said they felt as though they were experiencing their best self and seeing the world clearly for the first time. Another talked about realizing communication wasn't only about talking — that emotions, theirs and others', deserved attention before words did. These aren't the kinds of statements a placebo response usually produces. MDMA isn't a classical psychedelic in the way psilocybin or LSD are. It's an empathogen — a compound that increases feelings of trust, emotional openness, and connection. In a therapeutic context, that pharmacology is the point. The drug doesn't do the work; it lowers the walls so the work can happen. Therapists guide the session. The medicine softens the defenses that usually keep painful or confusing material out of reach. For autistic adults whose social anxiety is rooted in years of misread cues, social rejection, or trauma from being forced to mask, that softening can be the door. The therapy team in the Harbor-UCLA study reported no unexpected adverse reactions. Side effects matched what's been seen in other MDMA trials — fatigue, headaches, sensitivity to cold — and none were serious. Charles Grob, one of the study's authors, pointed to something the numbers don't quite capture: participants showed up to social situations afterward with more self-confidence. The settings that used to overwhelm them felt navigable. That's the kind of outcome that matters in a life, not just a paper. This work doesn't exist in a vacuum. Over the past decade, MDMA-assisted therapy has produced some of the strongest clinical results in any mental-health research program. The Multidisciplinary Association for Psychedelic Studies (MAPS) has shepherded MDMA through Phase 3 trials for PTSD, where the majority of participants in some studies no longer met diagnostic criteria after treatment. Psilocybin has shown promise for treatment-resistant depression. Ibogaine and ayahuasca are being studied for addiction and trauma. Ketamine clinics have proliferated across the U.S. Within that picture, the autism study is small but conceptually important. It expands the conversation beyond PTSD and depression. It suggests psychedelic-assisted therapy might be useful for populations that traditional psychiatry has often failed — not by curing autism (it's not a disease to cure) but by addressing the secondary anxiety that years of social difficulty can produce. It also raises uncomfortable questions for the field. Autistic adults are an underserved research population. Sample sizes are tiny. Funding is hard to find. The researchers behind the Harbor-UCLA work have been clear that they hope their paper sparks larger trials. A few things worth saying plainly, because the psychedelic conversation gets hyped fast. The honest framing: this is early evidence that points somewhere worth going. It's not a green light for self-treatment, and it's not a promise of healing. It's a reason to pay attention to where the science is heading. A lot of readers who follow MDMA research also find their way to ayahuasca, psilocybin, and other plant medicines used in retreat settings. The mechanisms differ. The traditions differ. But the underlying intuition is similar — that certain substances, in the right container, with the right preparation, can help people contact parts of themselves that ordinary life keeps locked away. Ayahuasca ceremonies, in particular, have drawn autistic adults and people with severe social anxiety to retreat centers in Peru, Costa Rica, and elsewhere. The reports are mixed and personal — some find profound shifts in how they relate to others; some find the intensity overwhelming. There's no clinical equivalent of the Harbor-UCLA study for ayahuasca and autism yet, and the small but vocal community of autistic ayahuasca participants tends to emphasize that preparation, facilitator skill, and aftercare matter enormously. If you're someone considering a retreat partly because social anxiety has shaped your life in painful ways, a few things are worth weighing carefully. Talk to your doctor, especially if you take SSRIs or other psychiatric medications — interactions with MDMA, ayahuasca, and similar substances can be serious. Ask retreat centers specifically about their experience with neurodivergent participants. Read the integration plan, not just the brochure. Alicia Danforth, one of the study's co-authors, has been working in this area for years and has spoken about wanting their paper to attract funding for larger trials. That's the bottleneck. Psychedelic research is expensive, slow, and politically fragile. Studies involving autistic adults face additional ethical scrutiny — appropriately so. But the pilot data is now on the record. Other research groups are paying attention. The broader MDMA-therapy program continues to move toward formal approval in the U.S., with regulatory decisions on PTSD treatment shaping what's possible for other indications. If MDMA-assisted therapy becomes a legal clinical option for PTSD, the path for studying it in other anxiety conditions — including social anxiety in autistic adults — gets a lot shorter. For now, the takeaway is modest but real. Twelve people sat through two carefully structured sessions with a compound that most of Western medicine spent forty years calling worthless, and they came out the other side describing social ease they hadn't felt before. That deserves more research, more funding, and more honest conversation about who psychedelic therapy could actually help. If something in this conversation speaks to you, the broader landscape of psychedelic and plant-medicine retreats can be browsed on our marketplace here — a useful place to start if you're researching options with an open mind and a careful one.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
Zen Meditation at Home: A Practical Guide for Beginners
Most of us don’t need another productivity hack. We need permission to stop. Zen meditation — or zazen, as practitioners call the sitting form — is one of the oldest, plainest answers to that craving. No app. No special clothes. Just you, a cushion, and the quiet stubbornness to sit down again tomorrow. If you’ve been circling this practice for a while, wondering whether it’s worth the trouble, this guide is for you. I’ll walk through what Zen actually is, where it came from, what science has bothered to measure, and how to set up a sustainable home practice without turning your spare room into a Kyoto temple. Zen is a form of Buddhist meditation that emphasises direct experience over doctrine. The word itself comes from the Chinese Chan, which traces back to the Sanskrit dhyana — roughly, “meditative absorption.” The practice predates almost every wellness trend you’ve heard of by about fifteen centuries, having taken shape in China around the 6th century CE before spreading through Korea, Japan, and eventually the West. Unlike guided visualisations or mantra-based techniques, Zen asks you to do something deceptively simple: sit, breathe, and notice. You don’t chase thoughts. You don’t banish them either. You let them drift across the mind the way clouds drift across a window. The aim isn’t a blissed-out trance — it’s a clear, awake presence with whatever is actually happening. Practitioners often describe it as the opposite of escapism. You’re not leaving the world; you’re finally arriving in it. Zen isn’t monolithic. Teachers across history have grouped the practice into rough categories, and knowing them helps you understand what kind of sitting you might actually be doing. For most beginners, Bompu Zen is the honest starting point. You can graduate to bigger questions later — or never. Both are fine. Meditation research has exploded in the past two decades, and Zen has had its share of attention. Studies on regular practitioners suggest measurable effects on attention, stress reactivity, and the recovery of focus after distraction. One often-cited experiment found that experienced Zen meditators returned to baseline breathing patterns faster after disruption than non-meditators — a small but interesting marker of mental regulation. Other research has looked at how Zen practice influences problem-solving and access to less filtered thinking. Practitioners who sat before a creative-association task tended to outperform those who didn’t. Read that result with a grain of salt — sample sizes are small, and meditation studies are notoriously hard to control. Still, the direction of the findings lines up with what experienced sitters describe: a quieter mind tends to make better decisions. The broader literature on meditation in general points to benefits across sleep, anxiety, mild depression, and emotional regulation. Zen isn’t a magic pill for any of these. It’s more like flossing — quietly cumulative, easy to skip, and unmistakably effective over years. The traditional story credits an Indian monk named Bodhidharma with bringing Chan to China in the 6th century. Whether the legends are accurate matters less than what came afterward: Chan absorbed strands of Taoism, became Seon in Korea by the 7th century, and crossed to Japan around the 12th, where the monk Dogen established the Soto school after returning from his own studies in China. Zen reached Europe and North America in fragmentary waves through the late 19th and early 20th centuries, with the scholar D.T. Suzuki doing much of the heavy lifting in translation. By the 1960s it had become part of the Western contemplative landscape, and by now it has been so thoroughly assimilated that most “mindfulness” apps owe Zen a quiet thank-you they’ll never send. Here’s the honest version. You don’t need a teacher to start, though you’ll probably want one eventually if the practice sticks. What you need first is a stable setup and a willingness to do the unglamorous thing — sit, again, tomorrow. Quiet corner. Same time every day if you can manage it. Mornings work for most people because the mind hasn’t fully loaded its to-do list yet. Ten minutes is plenty when you’re starting. Build up to twenty or thirty over weeks, not days. Forget the Instagram lotus. The best posture is the one you can sit in without grimacing. The classic Zen hand position is the cosmic mudra: right palm cradling the left, thumbs lightly touching to form a soft oval at the navel. If the thumbs collapse, you’re drifting. If they press hard, you’re tense. The mudra is a quiet feedback loop. Crown of the head lifts. Chin tucks slightly. Shoulders drop. The spine does the structural work so the rest of the body can let go. A collapsed posture invites a collapsed mind. This is the part beginners often skip. In traditional Zen, eyes stay half-open with an unfocused gaze on the floor about two or three feet ahead. It keeps you from drifting into daydreams or falling asleep. Closed eyes are fine if you’re struggling, but try the half-open gaze for a week and notice the difference. Don’t control the breath. Just feel it. When the mind wanders — and it will, constantly, often hilariously — return to the breath without scolding yourself. The returning is the practice. If you return a hundred times in ten minutes, you meditated a hundred times. That’s not failure. That’s the gym. Some honesty: the first weeks are usually uncomfortable. Your knee will hurt. Your back will protest. Your mind will produce shopping lists, old arguments, and elaborate fantasies about lunch. You’ll wonder if you’re doing it wrong. You’re not. This is the practice introducing itself. By week three or four, something subtle usually shifts. Not enlightenment — more like a small space opening between you and your own reactivity. You notice irritation before it becomes a snapped reply. You sleep slightly better. You stop checking your phone in the elevator. Small things, accumulating. If you’re drawn to Zen because you’re struggling with something heavier — addiction, depression, long-standing trauma — meditation can be a real ally, but it’s not a substitute for proper care. Sit, yes. Also talk to someone qualified. Home practice will carry you a long way. A residential retreat will carry you somewhere else entirely. Even a weekend of structured sitting — proper silence, multiple sessions a day, a teacher to ask the awkward questions — tends to compress months of insight into a few days. The catch is that retreats are uncomfortable on purpose. The structure exists precisely to confront the patterns you usually distract yourself away from. If you’re curious about going deeper, a range of curated meditation and contemplative retreats can be browsed on our marketplace here. Start tomorrow morning. Ten minutes. A cushion or a chair. The breath, the spine, the returning. That’s the whole thing. The rest is just practice.
Microdosing Mushrooms: What the Research Actually Shows About Psilocybin
Somewhere between the full-blown psychedelic trip and a regular Tuesday morning sits a quieter practice: microdosing. A crumb of dried mushroom — maybe a tenth of a gram — taken every few days, with no expectation of seeing the wallpaper breathe. People do it for focus. For mood. For creative work that won't unstick. For depression that hasn't budged in years. The question is whether any of it actually works, or whether we're all just very enthusiastic about placebo. The honest answer, as of 2026, is: somewhere in between, and the science is still catching up. If you're considering microdosing psilocybin — or any psychedelic — as part of your own recovery from addiction, depression, or just feeling stuck, here's what's actually known and what's still guesswork. A microdose is roughly one-tenth of a recreational dose. If a noticeable psychedelic experience kicks in around one gram of dried mushrooms, a microdose lands near 0.1 grams. Some people go even smaller. The point is that you shouldn't feel intoxicated. No visuals, no time dilation, no laughing at the ceiling. If you're tripping, you've overshot — that's a low dose, not a microdose. Psilocybin, the active compound in these mushrooms, gets converted in the body to psilocin, which binds to serotonin 2A receptors in the brain. At full doses, this rewiring produces the classic psychedelic experience — altered perception, dissolved ego, hallucinations, the works. At a microdose, the theory goes, you get subtle neurochemical effects without the cinematic ones: a small lift in mood, sharper attention, a looser kind of thinking. That's the theory. The evidence is messier. Here's where things get awkward. Several solid studies from the early 2020s — including placebo-controlled work that finally went beyond self-reported surveys — found that much of what people attribute to microdosing tracks closely with the placebo effect. In one widely cited trial, participants who thought they had taken a microdose reported nearly the same benefits as those who actually had. Expectation, it turns out, is a powerful drug all by itself. That doesn't mean microdosing is fake. It means we can't yet cleanly separate the chemistry from the belief. Both might be doing work. And given how much modern medicine accepts that mindset shapes outcome — see also: nearly every antidepressant trial ever — that's not nothing. It's just not the slam-dunk evidence that microdosing advocates sometimes claim. What the better studies do suggest is modest and worth taking seriously: Notice that last point. The studies showing the strongest mental-health outcomes almost all involve psychological support alongside the substance. Microdosing alone, with no therapy, no integration, no structure, gets you considerably less than microdosing inside a thoughtful framework. The mushroom isn't the treatment. The mushroom is one ingredient in the treatment. Microdosing has a reputation for being basically harmless — a sort of mushroom-flavored multivitamin. That's marketing, not science. Psilocybin remains a Schedule I substance in the U.S. and most other countries, which means unregulated supply, unknown potency, and zero quality control unless you're growing your own or sourcing from a meticulous friend. The actual reported side effects of microdosing include: And there's a bigger caution: people with a personal or family history of psychotic disorders — schizophrenia, bipolar I, schizoaffective disorder — should not microdose. Psychedelics can trigger or accelerate episodes in vulnerable people. This isn't theoretical. It's the single most important screening question a responsible facilitator will ask, and if nobody's asking you, that tells you something about who you're working with. No, and the difference matters. A retreat — whether it's psilocybin in Jamaica or the Netherlands, ayahuasca in Peru, or one of the legally sanctioned psilocybin programs now operating in Oregon and Colorado — uses a full dose in a held container with trained support. The intent is a single, intense experience that opens something up, followed by integration work to make sense of what surfaced. Microdosing is the opposite shape: subtle, repeated, woven into ordinary life. You go to work. You take a hike. You attend your kid's recital. The substance is supposed to fade into the background while quietly nudging your baseline. Some people use microdosing as preparation before a retreat or as part of integration afterward — both can make sense, though you should always check with the facilitators running your ceremony, because many traditions ask you to be substance-free for a meaningful window beforehand. If you're drawn to psilocybin because you're working through deep trauma, addiction, or treatment-resistant depression, the honest read is that a structured experience with proper support tends to do more than microdosing alone. Microdosing might help maintain gains or smooth out daily life. The heavy lifting often happens at higher doses with skilled people around you. A few practical things worth holding in mind before you decide anything: Microdosing is one small piece of a much larger conversation about psychedelics, master plants, and what we now call psychedelic-assisted recovery. The renaissance is real — clinical trials for psilocybin, MDMA, and ibogaine have produced some of the most striking results in psychiatry in decades. But the most dramatic outcomes come from full-dose, supported experiences, not from sprinkling tiny amounts into your morning coffee. If you're considering plant medicine because something in your life isn't working — addiction that won't lift, depression that grinds on, trauma that keeps replaying — it's worth thinking bigger than a microdose. A well-run psilocybin retreat, ayahuasca ceremony, or ibogaine program can do in a week what microdosing might do in a year, assuming microdosing is doing anything at all beyond placebo. For readers who want to explore the structured, supported route, a curated selection of psilocybin and plant-medicine retreats can be browsed on our marketplace here. Microdosing has its place. It's just probably not the whole answer — and anyone selling it as one is selling something other than the truth.
Ibogaine for Addiction: A Powerful Tool for Recovery
Ibogaine, a naturally occurring psychoactive compound found in the roots of the Tabernanthe iboga plant, has been used for centuries in traditional African medicine to treat various ailments, including addiction. In recent years, its potential as a treatment for addiction has gained significant attention, with many individuals claiming that it has helped them overcome their struggles with substance abuse. The story of how ibogaine can save lives is one that is both fascinating and complex. From its traditional use in African rituals to its modern-day application in addiction treatment, ibogaine has proven to be a powerful tool in the fight against addiction. In this article, we will delve into the world of ibogaine, exploring its history, mechanisms of action, and the experiences of those who have used it to overcome addiction. The use of ibogaine dates back to the 19th century, when it was first discovered by European colonizers in Africa. Initially, it was used in traditional medicine to treat a range of ailments, including fever, rheumatism, and even mental health disorders. However, it wasn't until the 1960s that ibogaine's potential as a treatment for addiction was first recognized. In the 1960s, a man named Howard Lotsof, who was struggling with heroin addiction, stumbled upon ibogaine while searching for a cure for his addiction. After using ibogaine, Lotsof reported that he had experienced a complete cessation of his withdrawal symptoms and craving for heroin. This experience sparked a renewed interest in ibogaine as a potential treatment for addiction, and since then, numerous studies have been conducted to investigate its efficacy. So, how does ibogaine work? The exact mechanisms of action are still not fully understood, but research suggests that ibogaine interacts with the brain's opioid receptors, reducing cravings and withdrawal symptoms. Ibogaine also appears to have a neuroprotective effect, helping to repair damage to the brain caused by long-term substance abuse. In addition to its effects on the brain, ibogaine has also been shown to have a profound impact on the user's psyche. Many individuals who have used ibogaine report experiencing intense visualizations, introspection, and a sense of spiritual awakening. These experiences are often described as life-changing, and are thought to play a key role in the long-term success of ibogaine treatment. While the science behind ibogaine is fascinating, it is the personal stories of those who have used it that truly bring its potential to life. From individuals who have struggled with addiction for years to those who have used ibogaine as a tool for personal growth and self-discovery, the experiences of ibogaine users are as diverse as they are compelling. One common theme that emerges from these stories is the sense of transformation that ibogaine can bring. Many users report feeling a deep sense of connection to themselves and the world around them, and a renewed sense of purpose and direction. Others describe experiencing a sense of freedom from the cycle of addiction, and a newfound ability to live life on their own terms. In conclusion, ibogaine is a powerful tool in the fight against addiction. With its rich history, complex mechanisms of action, and the compelling stories of those who have used it, ibogaine has proven itself to be a valuable resource for individuals seeking to overcome their struggles with substance abuse. While more research is needed to fully understand its potential, the evidence is clear: ibogaine has the power to transform lives, and deserves to be taken seriously as a treatment for addiction.
Ibogaine Retreats Explained: What a Psychospiritual Journey Actually Involves
The first time someone tells you about ibogaine, they usually say something like, “It showed me my entire life in one night.” That's the line. It gets repeated in recovery rooms, on forums, in late-night phone calls between people who've been chewing on the idea of a retreat for months. And it's not exactly wrong — but it's also not the whole story. Ibogaine is one of the heaviest plant medicines on the planet. Heavier than ayahuasca in some ways. Longer than psilocybin. More physically demanding than almost anything else in the psychedelic landscape. It's also the substance with the most credible track record for interrupting opioid addiction, which is why people in genuine crisis end up googling it at three in the morning. If that's where you are, or if you're somewhere further back in the research process, here's an honest look at what ibogaine retreats actually involve. Ibogaine is an alkaloid extracted from the root bark of the iboga shrub, which grows in the rainforests of central west Africa — Gabon, Cameroon, parts of Congo. In its traditional context, iboga is used by the Bwiti, an initiatory spiritual tradition where the plant is taken in large quantities during multi-day rites of passage. It's a master plant in the truest sense: revered, feared, treated with enormous care. In the modern psychedelic and addiction-recovery world, ibogaine usually shows up in one of two forms. There's purified ibogaine HCl, which is what most medical-model clinics use because the dose is precise. And there's total alkaloid extract or whole root bark, which keeps the full spectrum of compounds intact and is more common in psychospiritual or Bwiti-influenced retreats. Different teachers prefer different forms for different reasons, and neither is automatically better. The experience itself lasts a long time. Plan on twelve to twenty-four hours of active effects, followed by another day or two of what people call the “gray day” — exhausted, raw, processing. Most retreats keep you on-site for at least a week. The biggest single reason is addiction. Specifically opioids — heroin, fentanyl, oxycodone, methadone — because ibogaine has a documented ability to dramatically reduce or eliminate physical withdrawal in a single session. That's not marketing. It's been observed clinically since the 1960s, and there's enough peer-reviewed research now that several countries treat ibogaine as a legitimate (if still experimental) addiction intervention. People walk into a clinic strung out and walk out, days later, without the gnawing physical craving. That alone is reason enough that ibogaine retreats exist. But opioid recovery isn't the only doorway. Plenty of people arrive looking for something else entirely: Ibogaine has a reputation, deserved, for being unusually direct about showing you your own life. Where ayahuasca tends to move in waves of imagery and emotion, ibogaine often feels more like watching a documentary about yourself. The memories that surface are specific. The lessons feel almost lectured. People describe meeting parts of themselves they'd written off, or seeing a relationship in completely new terms, or understanding — finally — why they keep doing the thing they keep doing. You'll usually start in the evening, after a medical screening earlier in the day. The room is dark or low-lit. You're lying down — and you'll stay lying down, because ibogaine produces ataxia, which means your coordination is gone. Standing up is a bad idea for many hours. The first phase, often called the visionary phase, comes on within an hour or two. Eyes closed, you start seeing — and the word “seeing” is doing a lot of work here. Some people describe it as a flood of autobiographical memory played at high speed. Others get more symbolic, archetypal material. Many hear a buzzing or whirring sound, almost mechanical. There's frequently a sense of being shown something by an intelligence that isn't you. Whether you call that the plant, the unconscious, or something else is up to you. The second phase is more reflective. The flood slows. You're still inside the experience but able to think about it, examine specific scenes, ask questions and get answers. This can go on for hours. Time becomes essentially meaningless. The third phase is the long tail. Physical exhaustion, sensitivity to light and sound, sometimes nausea, and a strange kind of mental clarity that sits underneath the tiredness. Sleep often doesn't come for another day. When it finally does, it's usually deep. Ibogaine is the psychedelic with the most serious safety profile concerns, and any retreat worth its fee will tell you this upfront. The risk isn't really psychological — it's cardiac. Ibogaine prolongs the QT interval, which in plain language means it can disrupt the electrical rhythm of the heart. In a healthy screened person, in a properly run setting, this risk is manageable. In an unscreened person with an undiagnosed condition, it can be fatal. Non-negotiables when evaluating a retreat: If a retreat is cagey about any of these, walk away. There's no version of ibogaine where the spiritual depth justifies skipping the medical infrastructure. The retreats with the best long-term outcomes are also, without exception, the ones with the strictest screening. The ibogaine world is smaller than the ayahuasca world, but it's grown fast in the last few years, and not every operation is equal. A handful of things to look at: Lineage and training. Is the lead facilitator trained in a recognized tradition or by a recognized medical body? Bwiti-trained practitioners, ibogaine providers who came up through GITA-aligned programs, clinicians with addiction-medicine backgrounds — these are signals. Vague spiritual credentials are not. Integration support. The ceremony is maybe a third of the work. What happens in the weeks and months afterward decides whether the insight lands or evaporates. Reputable retreats offer post-retreat integration calls, group sessions, or referrals to integration coaches. If the relationship ends when you leave the property, that's a red flag. Honesty about what ibogaine can't do. If a retreat promises a cure, run. Ibogaine interrupts patterns. It opens a window. What you do with that window is on you — and on whatever support structure you build around it. A facilitator who says this plainly is more trustworthy than one who promises transformation. Reasonable group size. Ibogaine isn't a group ceremony in the ayahuasca sense. Each person needs close attention. Be skeptical of large cohorts. The preparation window matters more than people realize. A few practical things: Get your medications sorted with your prescribing doctor well in advance. SSRIs and SNRIs typically need to be tapered weeks before, not days. Methadone has its own long timeline. Buprenorphine has its own. Stimulants, including ADHD medications, need to be cleared. Do not improvise this part. Eat clean for at least a couple of weeks before — less sugar, less alcohol, more whole foods. Your body is about to do something difficult; show up rested. Sleep matters more than any superfood. Spend some honest time with the question of what you actually want from the experience. Not the spiritual version of the answer — the real version. “I want to stop using” is real. “I want to know why I've sabotaged every relationship I've had” is real. “I want to feel something other than numb” is real. Write it down. Bring it with you. And tell someone you trust what you're doing. Not for permission — you're an adult — but because integration is easier when you have at least one person who knows where you went and is curious to hear what came back with you. The week after is strange. You'll feel physically tender for a few days. Emotionally, many people report a kind of quiet — the constant background noise of craving or self-criticism turned way down. This is sometimes called the “afterglow,” and it can last weeks. It's a window. Use it. Build something during this period. Therapy appointments scheduled. New routines actually started. Honest conversations actually had. The ibogaine showed you the map; the walking is yours to do. People who treat the retreat as the end of the work tend to drift back toward where they started within months. People who treat it as the beginning tend to be having different conversations a year later. For readers who want to take this further, a range of vetted ibogaine and plant-medicine retreats can be browsed on our marketplace here. Take your time with the decision — the right retreat is worth waiting a few months for, and the wrong one isn't worth any price.
Psychedelics for PTSD: Real Stories of Healing With MDMA and Ayahuasca
The first time Nathan closed his eyes during the trial, he described it like a kid pulling back heavy curtains in a room he’d been afraid of for years. He wasn’t scared anymore. He was curious. That single shift — from dread to curiosity — is something I hear over and over from people who turn to psychedelics for PTSD, and it’s usually where the real work begins. Stories like Nathan’s are part of why interest in psychedelic-assisted therapy has gone from fringe to front-page. MDMA, psilocybin, ayahuasca, ibogaine — none of them are silver bullets, and anyone honest in this field will tell you that. But a growing body of research, plus thousands of personal accounts, suggests these compounds can do something traditional treatment often can’t: help a traumatized nervous system feel safe enough to actually process what happened. Below are several real accounts — drawn from veterans, survivors, and clinical-trial participants — of what it actually feels like to face PTSD with the help of plant medicine and psychedelics. I’ve sat with people during and after experiences like these. The patterns repeat. The details never do. PTSD is stubborn. SSRIs help some people a little. Talk therapy helps more people, but slowly, and not everyone. For combat veterans, sexual assault survivors, and people carrying the weight of childhood trauma, the standard menu can feel exhausted before they’ve really started. That’s where psychedelics — and the broader category of master plants — keep entering the conversation. The research is genuinely promising. MDMA-assisted therapy is in late-stage clinical trials with MAPS, and early data has been strong enough that the FDA granted it Breakthrough Therapy designation. Psilocybin is being studied for treatment-resistant depression, end-of-life anxiety, and trauma. Ayahuasca, traditionally brewed in the Amazon for centuries, has drawn veterans’ groups who travel to legal jurisdictions because they’ve simply run out of options at home. None of this means you should go book a flight tomorrow. It does mean the desperation a lot of trauma survivors feel — that nothing is working — is finally being met with serious science and serious facilitators. The question is whether a retreat or trial is the right fit for you, right now. One former special-operations sergeant I’ll call C., 37, spent sixteen years in the military. By the time she got her PTSD diagnosis, she was preparing for another deployment and quietly aware she was no longer fit to lead her team. Antidepressants didn’t move the needle. Rehab helped with the drinking. The trauma itself — childhood and what came later in uniform — sat untouched. She heard about ayahuasca on a podcast, fell down the research rabbit hole, and eventually ended up at a retreat in Mexico that combined psilocybin and MDMA in a ceremonial setting. Lying among other participants, eye mask on, music playing, her body started shaking — not from fear, she said, but from something almost warm. Her chest felt like it was being held open. What she keeps coming back to isn’t the visions. It’s the absence of shame. For a few hours she existed without the constant low hum of guilt that had followed her for decades. That’s not a cure. But for someone who’d forgotten what neutral even felt like, it was the first crack of daylight. Another veteran, a former paralegal and combat driver, joined a retreat in 2021 after a year of talk therapy and several months of one-on-one prep with a coach. The retreat itself required strict dieta beforehand — no caffeine, no sugar, no alcohol, no salt, no stimulants. Participants journaled. They talked in circles. They got clear on what they were actually there for. She described the ceremony as drifting in and out of consciousness. When she came to, she felt the brew moving inside her — up to her throat, down through her stomach, swirling in her pelvis. She kept repeating, quietly, thank you for healing me, thank you for showing me, for what she remembers as about four hours. She’s firm about one thing: psychedelics are not a one-and-done fix. “Healing should be multidisciplinary,” she told me. “It’s a buffet. You don’t eat one thing and hope it lasts forever.” That line should be tattooed on the inside of every retreat brochure. Rudy, an 18-year special forces operator, had never touched an illicit drug before his first ayahuasca ceremony. His marriage had collapsed. He’d had an emotional breakdown. The VA had offered him what he called a cornucopia of pharmaceuticals, and he’d watched what those same prescriptions had done to friends. He said no. The symptoms were textbook combat PTSD — waking up convinced he was still deployed, snapping at things that didn’t matter, suffocating in crowds. One night he came back to consciousness standing naked at his own front door with a pistol, certain his teammates were about to be overrun. It was his wife’s voice that pulled him back. He flew out for ayahuasca through a veterans-focused organization. Months later, he didn’t describe himself as fixed. He described himself as having a new template for processing experience. The combat memories are still there. They just don’t run the show anymore. He also, in his words, left several buckets of vomit at the retreat — and joked that the shaman called him a strong purger. That kind of humor, in my experience, is a good sign someone is genuinely on the other side of something. Not every story takes place in a jungle. Lori, 42, was one of the early participants in MAPS’s FDA-cleared MDMA trials. Her trauma history is the kind that breaks sentences in half: her brother’s overdose, a rape by someone she knew, and walking in on the aftermath of a murder-suicide committed by her own mother. She received MDMA in three guided sessions, sandwiched between talk-therapy preparation and structured integration afterward. What she stresses — and what facilitators stress — is that the integration phase is where a lot of the actual healing settles in. The drug isn’t the therapy. The drug opens a window. What you do with what you saw, over the following weeks and months, is the therapy. This is where I see retreats and trials fail people most often. The ceremony is dramatic. The aftermath is quiet. Without integration — journaling, therapy, somatic work, community, time — it’s easy to slide back into old grooves and wonder why the magic didn’t stick. If you’re reading this because you’re weighing a booking, here are the questions I’d want you sitting with before you wire any deposits: I’ll be honest — the psychedelic space attracts both genuine healers and a fair number of opportunists with good lighting. Vet your facilitators the way you’d vet a surgeon. Read participant accounts that aren’t on the retreat’s own website. Talk to people who attended a year ago, not last week — because the year-later picture is what actually matters. A lot of people, understandably, can’t afford a structured retreat or wait years for a trial. Microdosing and underground experiences are everywhere. Researchers in this field — including the ones running the trials — consistently warn that self-medicating powerful compounds without screening, set, setting, or support can surface material people aren’t prepared to hold. That’s not a moral judgment. It’s a practical one. Trauma stored in the body has its own logic. When it comes up uninvited, in a context with no facilitator and no integration, it can entrench rather than release. If you’re going to do this work, give yourself the conditions to do it well. What strikes me about the people in these stories isn’t the drama of the ceremonies. It’s the ordinariness of what they wanted afterward — to sleep through the night, to be present with their kids, to stop bracing against everything. Psychedelics didn’t hand that to them. The medicine cracked something open, and they did the unglamorous work of rebuilding from there. If any of this resonates and you want to take a careful next step, a curated selection of ayahuasca and psychedelic retreats — including options that work specifically with veterans and trauma — can be browsed on our marketplace here. Take your time. The right retreat will still be there next month.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
